Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Onconova Therapeutics, Inc. (ONTX)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -89.5% | -55.6% | -197.2% | -174.6% | -1031.3% | -601.2% | -548.5% | |
| ROIC (including intangibles) | 357.3% | -33.4% | -250.8% | -141.1% | -244.0% | 485.8% | -212.0% | 807.9% |
| ROE | -69.3% | -35.8% | -404.8% | -187.6% | -429.6% | 223.5% | -540.5% | -221.3% |
| ROA | -49.9% | -29.7% | -125.1% | -91.7% | -129.1% | -487.6% | -119.3% | -102.3% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 46.8 | 0.0 | 0.0 | 0.0 | 10.4 | 27.4 | 2.0 | 47.9 |
|